Stocktoria
HENRY SCHEIN INC HSIC
Nasdaq · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies · website · IPO 1995-11-03 · LEI
HENRY SCHEIN INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.2B | $12.7B | $12.3B | $12.6B | $12.4B | $10.1B | $10.0B | $13.2B | $12.5B | $11.6B |
| Gross profit | $4.1B | $4.0B | $3.9B | $3.8B | $3.7B | $2.8B | $3.1B | $2.9B | $2.7B | $3.2B |
| SG&A expense | $3.1B | $3.0B | $3.0B | $2.8B | $2.6B | $2.1B | $2.4B | $2.2B | $2.1B | $2.4B |
| Operating income | $653.0M | $621.0M | $615.0M | $747.0M | $852.0M | $535.0M | $718.3M | $600.6M | $669.8M | $771.6M |
| Interest expense | $150.0M | $131.0M | $87.0M | $35.0M | $27.0M | $41.0M | $50.8M | $76.0M | $51.1M | $31.9M |
| Income tax | $126.0M | $128.0M | $120.0M | $170.0M | $198.0M | $95.0M | $159.5M | $107.4M | $309.0M | $218.0M |
| Net income | $398.0M | $390.0M | $416.0M | $538.0M | $631.0M | $404.0M | $694.7M | $535.9M | $406.3M | $506.8M |
| EPS (diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 |
| Operating cash flow | $712.0M | $848.0M | $500.0M | $602.0M | $710.0M | $599.0M | $820.5M | $684.7M | $545.5M | $642.6M |
| Cash & equivalents | — | — | — | — | — | — | — | $56.9M | $158.0M | $62.4M |
| Inventory | $2.0B | $1.8B | $1.8B | $2.0B | $1.9B | $1.5B | $1.4B | $1.4B | $1.9B | $1.7B |
| Total assets | $11.2B | $10.2B | $10.6B | $8.6B | $8.5B | $7.8B | $7.2B | $8.5B | $7.9B | $6.8B |
| Total liabilities | $6.4B | $5.4B | $5.4B | $3.9B | $3.8B | $3.5B | $3.2B | $4.6B | $4.2B | $3.4B |
| Shareholders' equity | $3.9B | $4.0B | $4.3B | $4.1B | $4.1B | $4.0B | $3.6B | $3.5B | $2.8B | $2.8B |
Growth · year-over-year · Revenue CAGR 1.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.0% | +2.7% | -2.4% | +2.0% | +22.6% | +1.3% | -24.4% | +5.9% | +7.7% | +8.9% |
| Net income growth | +2.1% | -6.2% | -22.7% | -14.7% | +56.2% | -41.8% | +29.6% | +31.9% | -19.8% | +5.8% |
| EPS growth | +7.2% | -3.5% | -19.2% | -12.1% | +57.8% | -39.4% | +33.2% | +35.8% | -17.1% | +8.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-27. Facts plus Stocktoria's own computed scores — not investment advice.